See all Best Pharmaceutical Stocks 2026

BMRN Stock Analysis: Buy, Sell, or Hold?

BMRN - BioMarin Pharmaceuticals Inc

PHARMACEUTICAL PREPARATIONS
$68.53
-1.71 (-2.43%) ▼
5d: +11.5%
30d: +16.25%
90d: +27.97%
WAIT
LOW Confidence
Protect Your BMRN Gains
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026 0d
Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Aug 10, 2026 at $68.88 · last confirmed Aug 12, 2026

Strength: 7.7/10

Get Alerted When BMRN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: BMRN shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$121.33
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$75.33
9.0% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.4x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: BMRN is currently trading at $68.53, which is considered extended relative to its 30-day fair value range of $57.86 to $64.67. The stock's valuation (Forward PE: 10.3) is in line with its historical norms (9.4). At these levels, the market is pricing in 3.1% annual earnings growth.

Technical Outlook: Technically, BMRN is in a uptrend. Immediate support is located at $58.89, while resistance sits at $70.98.

Market Sentiment: BMRN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $90.32 (+31.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $57.86 - $64.67
Company Quality Score 35/100 (SELL)
Volume Confirmation HIGH
Confidence Score 27.1%

Protect Your Profits

BMRN is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range (+6.0% above its trading range)
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 31.8% below Wall St target ($90.32)
  • BULLISH: Expecting earnings turnaround to 3.1% growth with 19.9% revenue growth
  • WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $57.86 - $64.67
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $58.89
Resistance Level $70.98
Current Trend Uptrend
Technical data as of Aug 13, 2026

Fundamental Context

Forward P/E (Next Year Est.) 10.34
Wall Street Target $90.32 (+31.8%)
Revenue Growth (YoY) 19.9%
Earnings Growth (YoY) -81.3%
Profit Margin 2.1%
Valuation Premium vs History +3.1% premium
PE vs Historical 10.3 vs 9.4 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +3.1% (market-implied from PE analysis)
1-Year Target $70.65 (+3%)
2-Year Target $72.84 (+6%)
3-Year Target $75.10 (+10%)
3-Yr Target (if PE normalizes) (PE: 10→9) PE COMPRESSION $68.28 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.2, Growth: 31.7%) $306.47 (+347%)
Base: (SPY PE: 10.3, Growth: 31.7%) $156.63 (+129%)
Bear: (PE: 8.8, Growth: 31.7%) $133.14 (+94%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (14x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Forward PE: 14.01 | Forward EPS (Implied): $4.89
Bull Case $82.75 (+21%)
Analyst growth 15.0%, PE expands to 14.7
Base Case $68.53 (0%)
Market implied 0.0%, PE stable at 14.0
Bear Case $52.43 (-24%)
Severe decline -15.0%, PE contracts to 12.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 13, 2026 10:20 PM ET
Data refreshes hourly during market hours. Next update: 11:20 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is BMRN showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Charles Greg Guyer SELL 16486 shares 2026-03-11
Gregory R Friberg SELL 6326 shares 2026-02-26

Unlock Insider Activity

See real-time buying/selling by company executives for BMRN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DNLI
Denali Therapeutics Inc 		STRONG BUY
19 analysts 		$34 51 HOLD
INCY
Incyte Corporation 		HOLD
27 analysts 		$125 47 HOLD
RNA
Atrium Therapeutics, Inc… 		STRONG BUY
15 analysts 		$25 46 HOLD
MIRM
Mirum Pharmaceuticals Inc 		STRONG BUY
10 analysts 		$140 62 BUY
VRDN
Viridian Therapeutics Inc 		STRONG BUY
16 analysts 		$37 40 SELL
DNLI Denali Therapeuti…
51 HOLD
INCY Incyte Corporation
47 HOLD
RNA Atrium Therapeuti…
46 HOLD
MIRM Mirum Pharmaceuti…
62 BUY
VRDN Viridian Therapeu…
40 SELL

Advanced BMRN Option Strategies

Professional options setups generated by AI based on today's BMRN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BMRN

BMRN Technical Chart BMRN Price Prediction BMRN Earnings Date BMRN Investment Advisor BMRN Fair Price Analyzer BMRN Options Advisor BMRN Options Chain BMRN Options Analysis BMRN Competitors
Compare BMRN with Peers
BMRN vs INCY
Which one to buy?
BMRN vs ALNY
Which one to buy?
BMRN vs VRTX
Which one to buy?
BMRN vs REGN
Which one to buy?
BMRN vs BIIB
Which one to buy?
CORT vs BMRN
Winner: BMRN
SMMT vs BMRN
MDGL vs BMRN
INCY vs BMRN
Winner: INCY
UTHR vs BMRN
Winner: UTHR
APGE vs BMRN
Winner: BMRN
EXEL vs BMRN
CYTK vs BMRN
Winner: BMRN
REGN vs BMRN
BMRN vs HALO
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals